{
  "slug": "mygenecounsel",
  "name": "Mygenecounsel",
  "description": "My Gene Counsel provides a genomic result intelligence platform that helps health systems, diagnostic labs, and precision medicine programs keep genetic findings clinically current. It automatically notifies patients and providers about guideline changes, variant reclassifications, and new clinical options, extending existing genomic programs without manual follow-up.",
  "url": "https://optimly.ai/brand/mygenecounsel",
  "websiteUrl": "https://mygenecounsel.com/",
  "logoUrl": "https://logo.clearbit.com/mygenecounsel.com",
  "baiScore": 47.5,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "AI Clinical Decision Support Platforms",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-25T01:20:20.774Z",
  "verifiedVitals": {
    "website": "https://mygenecounsel.com",
    "category": "genomic information management",
    "what_it_does": "My Gene Counsel provides an activation layer that keeps genetic findings clinically current through three integrated tools: My Gene Screen, Living Lab Reports®, and Genetic Alerts. It offers patient education, reclassification alerts, and longitudinal engagement, automatically notifying patients and providers when guidelines change, variants are reclassified, or new options emerge.",
    "primary_audience": "health systems, diagnostic labs, precision medicine programs, biopharma, clinical trials, and payers",
    "core_product": "My Gene Screen, Living Lab Reports®, and Genetic Alerts",
    "parent_ownership": null,
    "named_competitors": null
  },
  "intentTags": {
    "problemIntents": [
      "Difficulty keeping genetic information current as science evolves",
      "Manual follow-up required for genetic results and reclassifications",
      "Challenges in identifying suitable patients for genetic testing",
      "Lack of immediate actionability for genetic test results",
      "Difficulty in finding and engaging biomarker-defined patient populations for precision medicine and clinical trials"
    ],
    "solutionIntents": [
      "Automated updates and alerts for genetic findings",
      "Longitudinal engagement and education for patients with genetic results",
      "Scalable platform for managing genomic data intelligence",
      "Tools for identifying patients who should be tested (My Gene Screen)",
      "Actionable reporting for genetic results (Living Lab Reports®)",
      "Alerts for variant reclassification, management guideline changes, and new clinical options (Genetic Alerts)",
      "Integration layer for existing genomic programs, testing platforms, and EHRs"
    ],
    "evaluationIntents": [
      "Comparison of genomic result intelligence platforms",
      "Review of automated genetic information update systems",
      "Assessment of patient engagement solutions for genetic findings",
      "Evaluation of precision medicine program support tools",
      "Analysis of integration capabilities for genetic data platforms with existing healthcare IT"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1790425787411
}